|
US2386796A
(en)
|
1942-08-05 |
1945-10-16 |
Bond Crown & Cork Co |
Extruding device
|
|
DE2855719A1
(de)
|
1978-12-22 |
1980-07-10 |
Siemens Ag |
Zahnaerztliche handstueckanordnung
|
|
US4336336A
(en)
|
1979-01-12 |
1982-06-22 |
President And Fellows Of Harvard College |
Fused gene and method of making and using same
|
|
AU545912B2
(en)
|
1980-03-10 |
1985-08-08 |
Cetus Corporation |
Cloned heterologous jive products in bacillies
|
|
ZA811368B
(en)
|
1980-03-24 |
1982-04-28 |
Genentech Inc |
Bacterial polypedtide expression employing tryptophan promoter-operator
|
|
NZ199722A
(en)
|
1981-02-25 |
1985-12-13 |
Genentech Inc |
Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
|
|
GR75411B
(https=)
|
1981-04-29 |
1984-07-16 |
Biogen Nv |
|
|
US4551433A
(en)
|
1981-05-18 |
1985-11-05 |
Genentech, Inc. |
Microbial hybrid promoters
|
|
US4405712A
(en)
|
1981-07-01 |
1983-09-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
LTR-Vectors
|
|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
|
CA1341302C
(en)
|
1983-02-22 |
2001-10-09 |
Rae Lyn Burke |
Yeast expression systems with vectors having gapdh or pyk promoters and synthesis of foreign protein
|
|
US4876197A
(en)
|
1983-02-22 |
1989-10-24 |
Chiron Corporation |
Eukaryotic regulatable transcription
|
|
JPS59166086A
(ja)
|
1983-03-09 |
1984-09-19 |
Teruhiko Beppu |
新規な発現型プラスミドとそれらを用いて仔牛プロキモシン遺伝子を大腸菌内で発現させる方法
|
|
US4546083A
(en)
|
1983-04-22 |
1985-10-08 |
Stolle Research & Development Corporation |
Method and device for cell culture growth
|
|
US4588684A
(en)
|
1983-04-26 |
1986-05-13 |
Chiron Corporation |
a-Factor and its processing signals
|
|
JPS59205983A
(ja)
|
1983-04-28 |
1984-11-21 |
ジエネツクス・コ−ポレイシヨン |
異種遺伝子を原核微生物で発現させる方法
|
|
US4663280A
(en)
|
1983-05-19 |
1987-05-05 |
Public Health Research Institute Of The City Of New York |
Expression and secretion vectors and method of constructing vectors
|
|
EP0127839B1
(en)
|
1983-05-27 |
1992-07-15 |
THE TEXAS A&M UNIVERSITY SYSTEM |
Method for producing a recombinant baculovirus expression vector
|
|
US4689406A
(en)
|
1983-08-10 |
1987-08-25 |
Amgen |
Enhancement of microbial expression of polypeptides
|
|
US4870008A
(en)
|
1983-08-12 |
1989-09-26 |
Chiron Corporation |
Secretory expression in eukaryotes
|
|
JPS6054685A
(ja)
|
1983-09-02 |
1985-03-29 |
Suntory Ltd |
改良発現ベクタ−およびその利用
|
|
EP0136907A3
(en)
|
1983-10-03 |
1986-12-30 |
Genentech, Inc. |
A xenogeneic expression control system, a method of using it, expression vectors containing it, cells transformed thereby and heterologous proteins produced therefrom
|
|
ZA848495B
(en)
|
1984-01-31 |
1985-09-25 |
Idaho Res Found |
Production of polypeptides in insect cells
|
|
US4880734A
(en)
|
1984-05-11 |
1989-11-14 |
Chiron Corporation |
Eukaryotic regulatable transcription
|
|
ATE102250T1
(de)
|
1984-05-11 |
1994-03-15 |
Chiron Corp |
Erhoehte hefetranskription unter verwendung einer hybridkonstruktion der promotorregion.
|
|
US5288641A
(en)
|
1984-06-04 |
1994-02-22 |
Arch Development Corporation |
Herpes Simplex virus as a vector
|
|
CA1282721C
(en)
|
1984-06-04 |
1991-04-09 |
Bernard Roizman |
Herpes simplex virus as a vector
|
|
US4738921A
(en)
|
1984-09-27 |
1988-04-19 |
Eli Lilly And Company |
Derivative of the tryptophan operon for expression of fused gene products
|
|
US4745056A
(en)
|
1984-10-23 |
1988-05-17 |
Biotechnica International, Inc. |
Streptomyces secretion vector
|
|
US4837148A
(en)
|
1984-10-30 |
1989-06-06 |
Phillips Petroleum Company |
Autonomous replication sequences for yeast strains of the genus pichia
|
|
US4762915A
(en)
|
1985-01-18 |
1988-08-09 |
Liposome Technology, Inc. |
Protein-liposome conjugates
|
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
CA1260858A
(en)
|
1985-03-28 |
1989-09-26 |
Lawrence S. Cousens |
Expression using fused genes providing for protein product
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4865974A
(en)
|
1985-09-20 |
1989-09-12 |
Cetus Corporation |
Bacterial methionine N-terminal peptidase
|
|
US4777127A
(en)
|
1985-09-30 |
1988-10-11 |
Labsystems Oy |
Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
|
|
JPS6296086A
(ja)
|
1985-10-21 |
1987-05-02 |
Agency Of Ind Science & Technol |
複合プラスミド
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US5091309A
(en)
|
1986-01-16 |
1992-02-25 |
Washington University |
Sindbis virus vectors
|
|
US4861719A
(en)
|
1986-04-25 |
1989-08-29 |
Fred Hutchinson Cancer Research Center |
DNA constructs for retrovirus packaging cell lines
|
|
ES2061482T3
(es)
|
1986-05-02 |
1994-12-16 |
Gist Brocades Nv |
Metodo para la identificacion de secuencias de señal secretora para sintesis de proteina extracelular en bacillus.
|
|
ATE247708T1
(de)
|
1986-10-02 |
2003-09-15 |
Massachusetts Inst Technology |
Verfahren zur regulierung der metabolischen stabilität von proteinen
|
|
JPS63123383A
(ja)
|
1986-11-11 |
1988-05-27 |
Mitsubishi Kasei Corp |
ハイブリツドプロモ−タ−、発現調節ｄｎａ配列および発現ベクタ−
|
|
GB8702816D0
(en)
|
1987-02-07 |
1987-03-11 |
Al Sumidaie A M K |
Obtaining retrovirus-containing fraction
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
CA1304020C
(en)
|
1987-03-23 |
1992-06-23 |
Meher H. Irani |
High level expression in yeast
|
|
US4980289A
(en)
|
1987-04-27 |
1990-12-25 |
Wisconsin Alumni Research Foundation |
Promoter deficient retroviral vector
|
|
WO1989001973A2
(en)
|
1987-09-02 |
1989-03-09 |
Applied Biotechnology, Inc. |
Recombinant pox virus for immunization against tumor-associated antigens
|
|
DK463887D0
(da)
|
1987-09-07 |
1987-09-07 |
Novo Industri As |
Gaerleader
|
|
ATE117375T1
(de)
|
1987-09-11 |
1995-02-15 |
Whitehead Biomedical Inst |
Transduktionsveränderte fibroblasten und ihre anwendung.
|
|
US4929555A
(en)
|
1987-10-19 |
1990-05-29 |
Phillips Petroleum Company |
Pichia transformation
|
|
JPH02500880A
(ja)
|
1987-11-18 |
1990-03-29 |
カイロン コーポレイション |
Ｎａｎｂｖの診断用薬およびワクチン
|
|
WO1989005349A1
(en)
|
1987-12-09 |
1989-06-15 |
The Australian National University |
Method of combating viral infections
|
|
CA1340772C
(en)
|
1987-12-30 |
1999-09-28 |
Patricia Tekamp-Olson |
Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
|
|
US4973551A
(en)
|
1988-01-15 |
1990-11-27 |
Merck & Co., Inc. |
Vector for the expression of fusion proteins and protein immunogens
|
|
WO1989009271A1
(en)
|
1988-03-21 |
1989-10-05 |
Viagene, Inc. |
Recombinant retroviruses
|
|
US5591624A
(en)
|
1988-03-21 |
1997-01-07 |
Chiron Viagene, Inc. |
Retroviral packaging cell lines
|
|
US5662896A
(en)
|
1988-03-21 |
1997-09-02 |
Chiron Viagene, Inc. |
Compositions and methods for cancer immunotherapy
|
|
US5206152A
(en)
|
1988-04-08 |
1993-04-27 |
Arch Development Corporation |
Cloning and expression of early growth regulatory protein genes
|
|
US5422120A
(en)
|
1988-05-30 |
1995-06-06 |
Depotech Corporation |
Heterovesicular liposomes
|
|
AP129A
(en)
|
1988-06-03 |
1991-04-17 |
Smithkline Biologicals S A |
Expression of retrovirus gag protein eukaryotic cells
|
|
DE68918189T2
(de)
*
|
1988-06-29 |
1995-01-12 |
Univ Rockefeller |
Neisseria-Vakzine.
|
|
WO1990002806A1
(en)
|
1988-09-01 |
1990-03-22 |
Whitehead Institute For Biomedical Research |
Recombinant retroviruses with amphotropic and ecotropic host ranges
|
|
EP0449958B9
(en)
*
|
1988-12-19 |
2003-05-28 |
American Cyanamid Company |
Meningococcal class 1 outer-membrane protein vaccine
|
|
US5217879A
(en)
|
1989-01-12 |
1993-06-08 |
Washington University |
Infectious Sindbis virus vectors
|
|
WO1990007936A1
(en)
|
1989-01-23 |
1990-07-26 |
Chiron Corporation |
Recombinant therapies for infection and hyperproliferative disorders
|
|
JPH04503306A
(ja)
|
1989-02-01 |
1992-06-18 |
ザ・ジェネラル・ホスピタル・コーポレーション |
単純ヘルペスウイルス１型発現ベクター
|
|
JP3140757B2
(ja)
|
1989-02-06 |
2001-03-05 |
デイナ・フアーバー・キヤンサー・インステイテユート |
パッケージング欠陥ｈｉｖプロウイルス、細胞系及びその使用
|
|
EP0388186A1
(en)
|
1989-03-17 |
1990-09-19 |
E.I. Du Pont De Nemours And Company |
External regulation of gene expression
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
CA2489769A1
(en)
|
1989-03-21 |
1990-10-04 |
Philip L. Felgner |
Expression of exogenous polynucleotide sequences in a vertebrate
|
|
CA2017507C
(en)
|
1989-05-25 |
1996-11-12 |
Gary Van Nest |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
NL9021328A
(nl)
|
1989-08-15 |
1992-06-01 |
Pasminco Australia Ltd |
Werkwijze en inrichting voor de absorptie van zinkdamp in gesmolten lood.
|
|
AU648261B2
(en)
|
1989-08-18 |
1994-04-21 |
Novartis Vaccines And Diagnostics, Inc. |
Recombinant retroviruses delivering vector constructs to target cells
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US5166057A
(en)
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
|
GB8919607D0
(en)
|
1989-08-30 |
1989-10-11 |
Wellcome Found |
Novel entities for cancer therapy
|
|
AU7007491A
(en)
|
1990-02-02 |
1991-08-08 |
Schweiz. Serum- & Impfinstitut Bern |
Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses
|
|
ZA911974B
(en)
|
1990-03-21 |
1994-08-22 |
Res Dev Foundation |
Heterovesicular liposomes
|
|
CA2039921A1
(en)
|
1990-04-16 |
1991-10-17 |
Xandra O. Breakefield |
Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication
|
|
WO1991018088A1
(en)
|
1990-05-23 |
1991-11-28 |
The United States Of America, Represented By The Secretary, United States Department Of Commerce |
Adeno-associated virus (aav)-based eucaryotic vectors
|
|
US5149655A
(en)
|
1990-06-21 |
1992-09-22 |
Agracetus, Inc. |
Apparatus for genetic transformation
|
|
EP0854193A1
(en)
|
1990-09-21 |
1998-07-22 |
Chiron Corporation |
Human retroviral packaging cell line
|
|
WO1992007945A1
(en)
|
1990-10-30 |
1992-05-14 |
Dana Farber Cancer Institute |
Cell type specific alteration of levels of gene products in neural cells
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
SE9003978D0
(sv)
|
1990-12-13 |
1990-12-13 |
Henrik Garoff |
Dna expressionssystem baserade paa ett virus replikon
|
|
WO1992011033A1
(en)
|
1990-12-20 |
1992-07-09 |
Arch Development Corporation |
Control of gene expression by ionizing radiation
|
|
DE69233013T2
(de)
|
1991-08-20 |
2004-03-04 |
The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer |
Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
|
|
FR2681786A1
(fr)
|
1991-09-27 |
1993-04-02 |
Centre Nat Rech Scient |
Vecteurs recombinants d'origine virale, leur procede d'obtention et leur utilisation pour l'expression de polypeptides dans des cellules musculaires.
|
|
IL103059A0
(en)
|
1991-09-30 |
1993-02-21 |
Boehringer Ingelheim Int |
Conjugates for introducing nucleic acid into higher eucaryotic cells
|
|
NZ244306A
(en)
|
1991-09-30 |
1995-07-26 |
Boehringer Ingelheim Int |
Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
|
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
|
WO1993010218A1
(en)
|
1991-11-14 |
1993-05-27 |
The United States Government As Represented By The Secretary Of The Department Of Health And Human Services |
Vectors including foreign genes and negative selective markers
|
|
GB9125623D0
(en)
|
1991-12-02 |
1992-01-29 |
Dynal As |
Cell modification
|
|
JPH07503372A
(ja)
|
1992-01-23 |
1995-04-13 |
バイカル・インコーポレイテッド |
生体外遺伝子導入
|
|
FR2688514A1
(fr)
|
1992-03-16 |
1993-09-17 |
Centre Nat Rech Scient |
Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
|
|
RU2077330C1
(ru)
*
|
1992-04-20 |
1997-04-20 |
Виктор Юрьевич Фролов |
Способ лечения менингококковой инфекции
|
|
EP0650370A4
(en)
|
1992-06-08 |
1995-11-22 |
Univ California |
METHODS AND COMPOSITIONS TARGETED ON SPECIFIC TISSUES.
|
|
CA2137361A1
(en)
|
1992-06-10 |
1993-12-23 |
W. French Anderson |
Vector particles resistant to inactivation by human serum
|
|
GB2269175A
(en)
|
1992-07-31 |
1994-02-02 |
Imperial College |
Retroviral vectors
|
|
JP3756944B2
(ja)
*
|
1992-09-15 |
2006-03-22 |
オルソ ダイアグノスティック システムズ，インコーポレーテッド |
エプスタイン−バーウィルスからの免疫反応性ペプチド
|
|
ATE404683T1
(de)
|
1992-09-25 |
2008-08-15 |
Aventis Pharma Sa |
Adenovirus vektoren für die übertragung fremder gene in zellen des zentralen nervensystems, insbesondere im gehirn
|
|
DE69333886T2
(de)
|
1992-11-18 |
2006-07-27 |
Arch Development Corp., Chicago |
Adenovirus-gelenkter Gen-Transfer zum Herz-und glattem vaskulären Muskel
|
|
EP1024198A3
(en)
|
1992-12-03 |
2002-05-29 |
Genzyme Corporation |
Pseudo-adenoviral vectors for the gene therapy of haemophiliae
|
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
|
US5348358A
(en)
|
1993-02-22 |
1994-09-20 |
Selick David A |
Contact lens insertion tool
|
|
DE4311651A1
(de)
|
1993-04-08 |
1994-10-13 |
Boehringer Ingelheim Int |
Virus für den Transport von Fremd-DNA in höhere eukaryotische Zellen
|
|
PT695169E
(pt)
|
1993-04-22 |
2003-04-30 |
Skyepharma Inc |
Lipossomas multivesiculares de ciclodextrina encapsulando compostos farmacologicos e metodos para a sua utilizacao
|
|
EP0733122A4
(en)
|
1993-05-26 |
1998-06-10 |
Us Health |
FUSION PROTEINS CONTAINING REP VIRUS PROTEIN ASSOCIATED WITH ADENOVIRUS AND BACTERIAL PROTEIN
|
|
FR2705686B1
(fr)
|
1993-05-28 |
1995-08-18 |
Transgene Sa |
Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
|
|
EP0705344B8
(en)
|
1993-06-24 |
2006-05-10 |
Advec Inc. |
Adenovirus vectors for gene therapy
|
|
SK282843B6
(sk)
|
1993-07-13 |
2002-12-03 |
Rhone-Poulenc Rorer S. A. |
Defektný rekombinantný adenovírus a farmaceutický prostriedok s jeho obsahom
|
|
WO1995004139A1
(en)
|
1993-07-27 |
1995-02-09 |
The Wistar Institute Of Anatomy And Biology |
Modified dna virus vectors and uses therefor
|
|
US5631236A
(en)
|
1993-08-26 |
1997-05-20 |
Baylor College Of Medicine |
Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
|
|
US5362865A
(en)
|
1993-09-02 |
1994-11-08 |
Monsanto Company |
Enhanced expression in plants using non-translated leader sequences
|
|
DK0814154T3
(da)
|
1993-09-15 |
2009-08-31 |
Novartis Vaccines & Diagnostic |
Rekombinante alfavirusvektorer
|
|
US6015686A
(en)
|
1993-09-15 |
2000-01-18 |
Chiron Viagene, Inc. |
Eukaryotic layered vector initiation systems
|
|
FR2710536B1
(fr)
|
1993-09-29 |
1995-12-22 |
Transgene Sa |
Usage anti-cancéreux d'un vecteur viral comportant un gène modulateur de la réponse immunitaire et/ou inflammatoire.
|
|
CA2171109A1
(en)
|
1993-10-01 |
1995-04-13 |
Zvi Ram |
Gene therapy of the nervous system
|
|
AU687117B2
(en)
|
1993-10-25 |
1998-02-19 |
Canji, Inc. |
Recombinant adenoviral vector and methods of use
|
|
US5693506A
(en)
|
1993-11-16 |
1997-12-02 |
The Regents Of The University Of California |
Process for protein production in plants
|
|
AU686277B2
(en)
|
1993-11-16 |
1998-02-05 |
Pacira Pharmaceuticals, Inc. |
Vesicles with controlled release of actives
|
|
FR2712603B1
(fr)
|
1993-11-18 |
1996-02-09 |
Centre Nat Rech Scient |
Virus recombinants, préparation et utilisation en thérapie génique.
|
|
JPH07241786A
(ja)
|
1994-03-08 |
1995-09-19 |
Fanuc Ltd |
産業用ロボットの制御装置
|
|
US6780406B1
(en)
|
1994-03-21 |
2004-08-24 |
The Regents Of The University Of Michigan |
Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene
|
|
US7252989B1
(en)
|
1994-04-04 |
2007-08-07 |
Board Of Regents, The University Of Texas System |
Adenovirus supervector system
|
|
CA2189067A1
(en)
|
1994-04-28 |
1995-11-09 |
Gary J. Nabel |
Gene delivery vector using plasmid dna packaged into an adenovirus and a packaging cell line
|
|
DE69535669T2
(de)
|
1994-05-09 |
2008-12-04 |
Oxford Biomedica (Uk) Ltd. |
Retrovirale vektoren mit verminderter rekombinationsrate
|
|
ATE336587T1
(de)
|
1994-06-10 |
2006-09-15 |
Genvec Inc |
Adenoviren-vektor systeme und zelllinien
|
|
FR2723588B1
(fr)
|
1994-08-12 |
1996-09-20 |
Rhone Poulenc Rorer Sa |
Adenovirus comprenant un gene codant pour la glutathion peroxydase
|
|
JPH11505128A
(ja)
|
1995-05-22 |
1999-05-18 |
カイロン コーポレイション |
キメラインテグラーゼタンパク質に媒介される真核生物ゲノム中へのベクター構築物の位置特異的組み込み
|
|
FR2751000B1
(fr)
|
1996-07-12 |
1998-10-30 |
Inst Nat Sante Rech Med |
Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
|
|
US6251433B1
(en)
|
1996-08-13 |
2001-06-26 |
Chiron Corporation |
Polycationic polymers
|
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
|
ZA982968B
(en)
*
|
1997-04-09 |
1998-10-27 |
Corixa Corp |
Compositions and methods for the treatment and diagnosis of breast cancer
|
|
GB9726398D0
(en)
*
|
1997-12-12 |
1998-02-11 |
Isis Innovation |
Polypeptide and coding sequences
|
|
EP1047784B2
(en)
|
1998-01-14 |
2015-03-18 |
Novartis Vaccines and Diagnostics S.r.l. |
Neissera meningitidis antigens
|
|
GB9810276D0
(en)
*
|
1998-05-13 |
1998-07-15 |
Smithkline Beecham Biolog |
Novel compounds
|
|
WO2000066741A2
(en)
*
|
1999-04-30 |
2000-11-09 |
Chiron S.P.A. |
Conserved neisserial antigens
|
|
NZ515935A
(en)
*
|
1999-05-19 |
2004-01-30 |
Chiron S |
Combination Neisserial compositions and vaccines for the prevention of infections due to Neisseria bacteria such as meningococcal meningitis
|